Skip to search.
 TSX Up 0.08% TSX Ventures Up 0.21%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.38 Down 0.01(0.21%) Feb 26, 4:00PM EST
|After Hours : 2.36 Down 0.02 (0.84%) Feb 26, 5:36PM EST
Add to Portfolio
Prev Close:2.38
Open:2.36
Bid:N/A
Ask:2.54 x 3000
1y Target Est:5.08
Beta:1.64
Earnings Date:Mar 2 - Mar 6 (Est.)
Day's Range:2.33 - 2.39
52wk Range:2.00 - 4.22
Volume:1,791,099
Avg Vol (3m):1,728,640
Market Cap:345.43M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 0.21%345.43M
BMYUp 0.39%102.15B
RHHBYDown 0.12%N/A
SNYDown 3.05%128.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.54
Quarterly EPS Est (Dec-14) :-0.18
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback